These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8846466)
1. Extended infusion of rtPA lysis of pulmonary emboli: influence of time after onset of symptoms on outcome. Aschauer M; Pilger E; Szolar DH; Flueckiger F; Hausegger K; Stark G; Groell R; Klein GE; Schreyer H Cardiovasc Intervent Radiol; 1995; 18(5):288-90. PubMed ID: 8846466 [TBL] [Abstract][Full Text] [Related]
3. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature]. Mele M; Mele A; La Torre PP; Cannone M G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813 [TBL] [Abstract][Full Text] [Related]
4. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2. Dalla-Volta S; Palla A; Santolicandro A; Giuntini C; Pengo V; Visioli O; Zonzin P; Zanuttini D; Barbaresi F; Agnelli G J Am Coll Cardiol; 1992 Sep; 20(3):520-6. PubMed ID: 1512328 [TBL] [Abstract][Full Text] [Related]
5. Thrombolytic therapy in canine pulmonary embolism. Comparative effects of urokinase and recombinant tissue plasminogen activator. Prewitt RM; Hoy C; Kong A; Gu SA; Greenberg D; Cook R; Chan SM; Ducas J Am Rev Respir Dis; 1990 Feb; 141(2):290-5. PubMed ID: 2105682 [TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism. Tebbe U; Graf A; Kamke W; Zahn R; Forycki F; Kratzsch G; Berg G Am Heart J; 1999 Jul; 138(1 Pt 1):39-44. PubMed ID: 10385761 [TBL] [Abstract][Full Text] [Related]
14. Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism. Verstraete M; Miller GA; Bounameaux H; Charbonnier B; Colle JP; Lecorf G; Marbet GA; Mombaerts P; Olsson CG Circulation; 1988 Feb; 77(2):353-60. PubMed ID: 3123091 [TBL] [Abstract][Full Text] [Related]
15. Effects of hydralazine and increased cardiac output on recombinant tissue plasminogen activator-induced thrombolysis in canine pulmonary embolism. Prewitt RM; Downes AM; Gu SA; Chan SM; Ducas J Chest; 1991 Mar; 99(3):708-14. PubMed ID: 1899825 [TBL] [Abstract][Full Text] [Related]
16. [Pulmonary embolism: which thrombolytic should be chosen?]. Pacouret G; Augusseau-Richard MP; Dessenne X; Pagot O; Charbonnier B Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1763-7. PubMed ID: 8815837 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism. Diehl JL; Meyer G; Igual J; Collignon MA; Giselbrecht M; Even P; Sors H Am J Cardiol; 1992 Dec; 70(18):1477-80. PubMed ID: 1442621 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152 [TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy of acute pulmonary embolism: current status and future potential. Goldhaber SZ; Meyerovitz MF; Markis JE; Kim D; Kessler CM; Sharma GV; Vaughan DE; Selwyn AP; Dawley DL; Loscalzo J J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):96B-104B. PubMed ID: 3117862 [TBL] [Abstract][Full Text] [Related]
20. Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator. Come PC; Kim D; Parker JA; Goldhaber SZ; Braunwald E; Markis JE J Am Coll Cardiol; 1987 Nov; 10(5):971-8. PubMed ID: 2959713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]